Public Employees Retirement System of Ohio bought a new stake in Agilent Technologies, Inc. (NYSE:A – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 93,601 shares of the medical research company’s stock, valued at approximately $12,433,000.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Agilent Technologies by 4.3% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock worth $82,712,000 after purchasing an additional 24,687 shares in the last quarter. Bank of Nova Scotia acquired a new stake in shares of Agilent Technologies in the 2nd quarter valued at about $58,539,000. Dudley & Shanley Inc. boosted its position in shares of Agilent Technologies by 25.9% in the 2nd quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock valued at $9,232,000 after purchasing an additional 14,300 shares during the period. BIP Wealth LLC purchased a new position in Agilent Technologies during the 2nd quarter worth approximately $834,000. Finally, Crossmark Global Holdings Inc. increased its position in Agilent Technologies by 39.6% during the fourth quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company’s stock worth $4,615,000 after buying an additional 9,615 shares during the period.
Key Headlines Impacting Agilent Technologies
Here are the key news stories impacting Agilent Technologies this week:
- Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
- Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
- Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
- Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.
Analyst Ratings Changes
Check Out Our Latest Research Report on Agilent Technologies
Agilent Technologies Stock Performance
NYSE:A opened at $154.47 on Monday. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. The firm has a market cap of $43.63 billion, a price-to-earnings ratio of 30.41, a price-to-earnings-growth ratio of 2.34 and a beta of 1.25. The firm’s fifty day moving average price is $140.30 and its 200 day moving average price is $127.04. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $163.75.
Agilent Technologies (NYSE:A – Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. During the same quarter in the prior year, the firm earned $1.37 EPS. Agilent Technologies’s quarterly revenue was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, sell-side analysts expect that Agilent Technologies, Inc. will post 6.2 EPS for the current year.
About Agilent Technologies
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Featured Stories
- Five stocks we like better than Agilent Technologies
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
